VRT:NYSEVertiv Holdings, LLC Analysis
Data as of 2026-03-10 - not real-time
$264.35
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Vertiv Holdings (VRT) is trading well above its 20‑day, 50‑day and 200‑day moving averages at $264.35, indicating a strong bullish trend, but the RSI of 66 hints at near‑term overbought conditions. Technical momentum is mixed: the MACD histogram is negative and the signal line is bearish, while price sits just below the 52‑week high of $266.67 and the identified resistance level of $266.65. Valuation metrics are stretched – the forward PE of 33.5 and trailing PE of 70.9 dwarf the industry average PE of 29.5, and the DCF‑derived fair value of $126.6 suggests a ~44% downside from current levels. The stock exhibits very high volatility (≈84% 30‑day) and a beta of 2.1, underscoring heightened market sensitivity. On the fundamentals side, revenue grew 22.7% YoY, margins remain solid (gross 36%, operating 21%), and ROE is an impressive 41.8%, but leverage is elevated with a debt‑to‑equity of 81.9% and net debt exceeding $1.3 B. Recent news adds momentum: a quarterly dividend was declared, earnings beat expectations, the company was added to the S&P 500, and demand for data‑center infrastructure continues to surge, all supporting a bullish outlook despite the lofty price.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical resistance and overbought RSI
- Bearish MACD histogram signaling possible pullback
- Elevated valuation relative to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings beat and accelerating revenue growth
- Inclusion in the S&P 500 boosting institutional demand
- Robust operating margins and high ROE supporting earnings expansion
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable low‑payout dividend backed by cash generation
- Long‑term data‑center and AI infrastructure tailwinds
- Valuation premium remains a risk despite solid fundamentals
Key Metrics & Analysis
Financial Health
Revenue Growth22.70%
Profit Margin13.03%
P/E Ratio70.9
ROE41.81%
ROA11.12%
Debt/Equity81.90
P/B Ratio25.7
Op. Cash Flow$2.1B
Free Cash Flow$1.4B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI66.5
Support$195.84
Resistance$266.65
MA 20$243.95
MA 50$203.81
MA 200$160.45
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$126.64
Target Price$263.20
Upside/Downside-0.44%
GradeOvervalued
TypeGrowth
Dividend Yield0.10%
Risk Assessment
Beta2.11
Volatility83.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.